Centene shares jump as Q3 earnings beat estimates, guidance raised

Published 29/10/2025, 11:12
© Reuters.

Investing.com -- Centene Corporation (NYSE:CNC) shares surged more than 10% premarket on Wednesday after the healthcare insurer reported third-quarter earnings that significantly exceeded analyst expectations and raised its full-year outlook.

The St. Louis-based company posted adjusted earnings of $0.50 per share for the third quarter, handily beating the analyst consensus estimate of -$0.16. Revenue came in at $49.69 billion, surpassing the $47.83 billion analysts had expected and representing a 22% increase from the same period last year. The company also raised its full-year 2025 adjusted earnings guidance to at least $2.00 per share, up from its previous forecast of $1.75 and well above the analyst consensus of $1.67.

"Our third quarter results and increased full year outlook demonstrate tangible progress against the near-term milestones we laid out for investors in July," said Sarah M. London, Chief Executive Officer of Centene. "While much work remains ahead, our organization remains focused on driving margin improvement, delivering outcomes for our members, and positioning the business for long-term success."

Despite the strong adjusted results, Centene reported a GAAP loss of $13.50 per share due to a $6.7 billion non-cash goodwill impairment charge. The company attributed this impairment to market conditions in July 2025, including the One Big Beautiful Bill Act and a decline in its stock price.

Premium and service revenues increased 22% YoY to $44.9 billion, driven primarily by growth in the Medicare Prescription Drug Plan business, Marketplace expansion, and Medicaid rate increases, which offset lower Medicaid membership.

The company’s health benefits ratio rose to 92.7% from 89.2% in the same quarter last year, reflecting increased Marketplace medical costs and higher Medicaid costs, particularly in behavioral health and home health services.

Centene’s selling, general and administrative expense ratio improved to 7.0% from 8.3% in the prior-year quarter, as the company continued to leverage expenses over higher revenues.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.